Show
10
20
30
40
results per page
Impact of Frailty and Sarcopenia on Post-COVID Recovery
Afilalo, Jonathan |
CIUSSS de Centre-Ouest-de-l'Ile-de-Montréal-Jewish General | Operating Grant | $470,179
CIHR Quebec 2021
Read More
Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract
Hobman, Tom C |
University of Alberta | Operating Grant | $499,130
CIHR Alberta 2021
Read More
Developing and evaluating an online intervention to improve the uptake and maintenance of protective behaviours against COVID‑19 among young adults in Canada
Campbell, Tavis S |
The University of Calgary | Project Grant | $271,575
CIHR Alberta 2021
Read More
COVID-19 Variant Supplement – Characterization of Covid-19 infection in rheumatoid arthritis patients- the CoViD-in-RA project
Roux, Sophie |
Université de Sherbrooke | Operating Grant | $50,000
CIHR Quebec 2021
Read More
COVID-19 Variant Supplement – A low-cost, portable, and decentralized microfluidic device for detecting SARS-CoV-2 neutralizing antibodies
Little, Dustin J |
Ryerson University | Operating Grant | $50,000
CIHR Ontario 2021
Read More
kitatipithitamak mithwayawin: Evaluating impacts of an existing Indigenous-led project on COVID-19, which includes past work on risk communication, present work on digital health, and a future international gathering for impacted Indigenous communities around the world.
Mclachlan, Stephane M |
University of Manitoba | Other | $200,000
CIHR Manitoba 2021
Read More
A proposal to evaluate safer supply pilot programs in Canada
Werb, Daniel M |
Unity Health Toronto | Operating Grant | $2,096,137
CIHR Ontario 2021
Read More
Pregnant and Lactating Individuals & Newborns COVID‑19 Vaccination Study
El-Chaar, Darine |
Ottawa Hospital Research Institute | Operating Grant | $500,000
CIHR Ontario 2021
Read More
COVID-19 Variant Supplement – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment
Lemieux, Joanne M |
University of Alberta | Operating Grant | $50,000
CIHR Alberta 2021
Read More
COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase
James, Michael N |
University of Alberta | Operating Grant | $50,000
CIHR Alberta 2021
Read More